Antonio Recchiuti Selected Research

Antonio Recchiuti Research Topics

Disease

25	Inflammation (Inflammations) 11/2023 - 11/2009
6	Cystic Fibrosis (Mucoviscidosis) 11/2023 - 10/2017
4	Peritonitis 07/2014 - 11/2009
3	Hypoxia (Hypoxemia) 12/2023 - 01/2019
2	Sickle Cell Anemia (Hemoglobin S Disease) 12/2023 - 01/2019
2	Anemia 10/2023 - 03/2023
2	Reperfusion Injury 03/2023 - 11/2009
2	Neoplasms (Cancer) 06/2022 - 04/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2012 - 06/2007
1	Lung Diseases (Lung Disease) 11/2023
1	Hereditary Spherocytosis 10/2023
1	Virus Diseases (Viral Diseases) 10/2023
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2023
1	Non-alcoholic Fatty Liver Disease 01/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Iron Overload 01/2023
1	Abdominal Obesity 01/2023
1	Squamous Cell Carcinoma of Head and Neck 06/2022
1	COVID-19 01/2021
1	Infections 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2019
1	Blister (Bulla) 12/2017
1	Breast Neoplasms (Breast Cancer) 10/2016
1	Essential Thrombocythemia 02/2010
1	Polycythemia Vera 08/2008
1	Atherosclerosis 06/2007
1	Hyperhomocysteinemia 06/2007

Drug/Important Bio-Agent (IBA)

13	LipidsIBA 11/2023 - 11/2009
7	resolvin D1IBA 11/2023 - 05/2012
5	MicroRNAs (MicroRNA)IBA 10/2017 - 02/2011
5	LipoxinsIBA 10/2016 - 11/2009
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023 - 08/2008
4	lipoxin A4IBA 10/2017 - 02/2015
3	CytokinesIBA 09/2020 - 11/2009
3	Proteins (Proteins, Gene)FDA Link 10/2016 - 01/2012
2	Interleukin-10 (Interleukin 10)IBA 11/2023 - 05/2012
2	mitapivatIBA 10/2023 - 01/2023
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2023 - 02/2011
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
2	AutacoidsIBA 04/2021 - 09/2020
2	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 10/2016 - 02/2015
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2016 - 03/2012
2	LigandsIBA 02/2015 - 01/2010
2	ZymosanIBA 07/2014 - 05/2012
2	Eicosapentaenoic AcidIBA 02/2011 - 01/2010
2	ThromboxanesIBA 02/2010 - 08/2008
1	NF-kappa B (NF-kB)IBA 12/2023
1	InflammasomesIBA 12/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2023
1	epeleutonIBA 12/2023
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 11/2023
1	ChemokinesIBA 11/2023
1	SugarsIBA 11/2023
1	Imatinib Mesylate (Gleevec)FDA Link 03/2023
1	Tyrosine Kinase InhibitorsIBA 03/2023
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 03/2023
1	ivacaftor drug combination tezacaftorIBA 01/2023
1	Pyruvate KinaseIBA 01/2023
1	elexacaftorIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 06/2022
1	RNA (Ribonucleic Acid)IBA 06/2022
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2021
1	LeptinIBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	CateninsIBA 12/2017
1	VinculinIBA 12/2017
1	cadherin 5IBA 12/2017
1	PaxillinIBA 12/2017
1	ChromatinIBA 10/2016
1	Histones (Histone)IBA 10/2016
1	Lysine (L-Lysine)FDA Link 10/2016
1	Messenger RNA (mRNA)IBA 10/2016
1	coactivator-associated arginine methyltransferase 1IBA 07/2014
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 07/2014
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 07/2014
1	Docosahexaenoic AcidsIBA 07/2014
1	Histone Deacetylase InhibitorsIBA 10/2012
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 10/2012
1	NucleotidesIBA 03/2012
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 10/2010
1	Cyclooxygenase 1IBA 02/2010
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2010
1	5S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA 01/2010
1	CD40 Ligand (CD40L)IBA 06/2007

Therapy/Procedure

2	Therapeutics 03/2023 - 02/2010
1	Splenectomy 10/2023
1	Investigational Therapies (Experimental Therapy) 04/2021
1	Oral Administration 01/2019